44
Views
0
CrossRef citations to date
0
Altmetric
Editorial

How Do Viruses Interfere With Toll-Like Receptor 4?

, &
Pages 243-246 | Received 03 Mar 2017, Accepted 13 Mar 2017, Published online: 08 Jun 2017

References

  • Shirey KA , LaiW, PatelMCet al. Novel strategies for targeting innate immune responses to influenza . Mucosal Immunol.9 ( 5 ), 1173 – 1182 ( 2016 ).
  • Krawczyk CM , HolowkaT, SunJet al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation . Blood115 ( 23 ), 4742 – 4749 ( 2010 ).
  • Everts B , AmielE, HuangSCet al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKvarepsilon supports the anabolic demands of dendritic cell activation . Nat. Immunol.15 ( 4 ), 323 – 332 ( 2014 ).
  • O’Neill LA , PearceEJ . Immunometabolism governs dendritic cell and macrophage function . J. Exp. Med.213 ( 1 ), 15 – 23 ( 2016 ).
  • Perrin-Cocon L , Aublin-GexA, SestitoSEet al. TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection . Sci. Rep.7, 40791 ( 2017 ).
  • Reyna SM , GhoshS, TantiwongPet al. Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects . Diabetes57 ( 10 ), 2595 – 2602 ( 2008 ).
  • Erridge C . The roles of Toll-like receptors in atherosclerosis . J. Innate Immun.1 ( 4 ), 340 – 349 ( 2009 ).
  • Pal D , DasguptaS, KunduRet al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance . Nat. Med.18 ( 8 ), 1279 – 1285 ( 2012 ).
  • Rallabhandi P , PhillipsRL, BoukhvalovaMSet al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2 . MBio3 ( 4 ), e00218 – e00212 ( 2012 ).
  • Okumura A , PithaPM, YoshimuraA, HartyRN . Interaction between Ebola virus glycoprotein and host toll-like receptor 4 leads to induction of proinflammatory cytokines and SOCS1 . J. Virol.84 ( 1 ), 27 – 33 ( 2010 ).
  • Modhiran N , WattersonD, MullerDAet al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity . Sci. Transl. Med.7 ( 304 ), 304ra142 ( 2015 ).
  • Haynes LM , MooreDD, Kurt-JonesEA, FinbergRW, AndersonLJ, TrippRA . Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus . J. Virol.75 ( 22 ), 10730 – 10737 ( 2001 ).
  • Jude BA , PobezinskayaY, BishopJet al. Subversion of the innate immune system by a retrovirus . Nat. Immunol.4 ( 6 ), 573 – 578 ( 2003 ).
  • Rolland A , Jouvin-MarcheE, ViretC, FaureM, PerronH, MarchePN . The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses . J. Immunol.176 ( 12 ), 7636 – 7644 ( 2006 ).
  • Agaugue S , Perrin-CoconL, AndreP, LotteauV . Hepatitis C lipo-Viro-particle from chronically infected patients interferes with TLR4 signaling in dendritic cell . PLoS ONE2 ( 3 ), e330 ( 2007 ).
  • Perrin-Cocon L , AgaugueS, DiazOet al. Th1 disabled function in response to TLR4 stimulation of monocyte-derived DC from patients chronically-infected by hepatitis C virus . PLoS One3 ( 5 ), e2260 ( 2008 ).
  • Escudero-Perez B , VolchkovaVA, DolnikO, LawrenceP, VolchkovVE . Shed GP of Ebola virus triggers immune activation and increased vascular permeability . PLoS Pathogens10 ( 11 ), e1004509 ( 2014 ).
  • Shingai M , AzumaM, EbiharaTet al. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction . Int. Immunol.20 ( 9 ), 1169 – 1180 ( 2008 ).
  • Shirey KA , LaiW, ScottAJet al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection . Nature497 ( 7450 ), 498 – 502 ( 2013 ).
  • Cighetti R , CiaramelliC, SestitoSEet al. Modulation of CD14 and TLR4.MD-2 activities by a synthetic lipid A mimetic . Chembiochem15 ( 2 ), 250 – 258 ( 2014 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.